Fredric N. Eshelman, Director, 10% Owner at Furiex Pharmaceuticals, Inc. (FURX), bought 45,307 shares at $23.45 ($1.1M) on 2012-03-13, disclosed to the SEC on 2012-03-15.
Open-market purchase of $1.1M FURX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.45 | 22,594 | $530K | 49.6% |
| 2 | $23.75 | 22,713 | $539K | 50.4% |
| Total | $23.60 avg | 45,307 | $1.1M | 100% |
| Filing → |
| LQDA | SELL | 2021-01-21 | $872K | — | Filing → |
| LQDA | SELL | 2021-01-19 | $81K | — | Filing → |
| LQDA | SELL | 2021-01-15 | $219K | — | Filing → |